hexyon
sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - bóluefni - hexyon (dtap-ipv-hb-hib) er ætlað fyrir aðal og orku bólusetningu ungbarna og smábörn frá sex vikna gegn barnaveiki, stífkrampa, stífkrampa, lifrarbólgu b, mænusótt og innrásar sjúkdóma sem orsakast af haemophilus influenzae gerð b (hib). notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.
natriumklorid fresenius kabi leysir fyrir stungulyf 9 mg/ml
fresenius kabi ab - natrii chloridum - leysir fyrir stungulyf - 9 mg/ml
azithromycin stada mixtúruduft, dreifa 40 mg/ml
stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
boostrix polio stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta
calcium sandoz freyðitafla 500 mg
sandoz a/s - calcii carbonas; calcii lacto-gluconas - freyðitafla - 500 mg
míron smelt munndreifitafla 15 mg
teva b.v.* - mirtazapinum inn - munndreifitafla - 15 mg
míron smelt munndreifitafla 30 mg
teva b.v.* - mirtazapinum inn - munndreifitafla - 30 mg
rizatriptan sumar pharma (rizatriptan ratiopharm) munndreifitafla 10 mg
alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg
singulair tuggutafla 4 mg
n.v. organon* - montelukastum natríum - tuggutafla - 4 mg
montelukast ratiopharm (montelukast teva) tuggutafla 4 mg
teva sweden ab - montelukastum natríum - tuggutafla - 4 mg